Men’s Health

Come Out For Health: National LGBT Health Awareness Week

By | Health Policy, LGBT Health | No Comments
March 26–30, 2012 is National LGBT Health Awareness Week, highlighting the disparities in access to culturally competent care and positive health outcomes between lesbian, gay, bisexual, and transgender (LGBT) people and their heterosexual counterparts. The health of the LGBT community has long been at the heart of Fenway’s mission; and while we have seen great progress, we still have a long journey to true health equity. LGBT people have unique health and wellness needs and continue to be impacted by health disparities. For instance: Compared to other men, MSM are at increased risk of major depression during adolescence and adulthood, 
Read More
Cover Your Butt with Gardasil

Young, HIV-Postive MSM: Cover Your Butt Against HPV

By | HIV/AIDS, LGBT Health, Youth | No Comments
The Centers for Disease Control and Prevention (CDC) estimates that gay and bisexual men (men who have sex with other men) are about 17 times more likely to develop anal cancer than men who only have sex with women. HIV-positive males who have sex with males are at increased risk of developing anal cancer and/or genital warts compared to the general population. However, those who receive the Gardasil vaccine could be protected. The Gardasil vaccine has been approved by the Food and Drug Administration for use in HIV-negative young men and women to prevent transmission of the human papillomavirus (HPV), 
Read More

Policy Focus: Why Gather Data on Sexual Orientation and Gender Identity in Clinical Settings

By | Health Care, Health Policy, LGBT Health | No Comments
This month The Fenway Institute launched a series of Policy Focus briefs to highlight the importance of gathering sexual orientation and gender identity data in clinical settings. The first, Why gather data on sexual orientation and gender identity in clinical settings explains how gathering such data will help us understand LGBT health disparities, and how it is consistent with key recommendations in Healthy People 2020, the 2011 Institute of Medicine report on LGBT health issues and research gaps, and the Affordable Care Act. Gathering such data in electronic health records (EHRs) is especially important.   Gathering such data is vital 
Read More

New York Times: Questions on PrEP

By | HIV/AIDS | One Comment
Last year, a groundbreaking study (for which the Fenway Institute served as one of two U.S. test sites) showed that taking HIV medicines before becoming infected (known as Pre-Exposure Prophylaxis, or PrEP) greatly reduced the risk of HIV transmission in men who have sex with men. The study, called iPrEx, showed that high-risk individuals who took a single daily tablet containing two widely used HIV medications experienced an average of 43.8 percent fewer HIV infections than those who took a placebo pill. But how and when to put these findings into practice isn’t entirely clear, as this New York Times 
Read More